Literature DB >> 21196156

Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.

Naoyuki Takahashi1, Kazuhiro Maeda, Akihiro Ishihara, Shunsuke Uehara, Yasuhiro Kobayashi.   

Abstract

Osteoclasts develop from monocyte-macrophage lineage cells under the regulation of osteoblasts. Osteoblasts express two cytokines essential for osteoclastogenesis, macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-KappaB ligand (RANKL). Osteoblasts also produce osteoprotegerin (OPG), a decoy receptor for RANKL, which inhibits the interaction between RANKL and RANK, a receptor of RANKL. Bone resorption-stimulating factors act on osteoblasts to regulate RANKL and OPG expression. Nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) is a master transcription factor for osteoclast differentiation. The immunoreceptor tyrosine-based activation motif (ITAM)-mediated signal was discovered as a co-stimulatory signal in RANKL-induced osteoclastogenesis. Wnt proteins activate two pathways: beta-catenin-dependent canonical and beta-catenin-independent noncanonical pathways. Wnt proteins promote differentiation of osteoblasts through the canonical pathway. The canonical pathway in osteoblasts also suppresses osteoclastogenesis through up-regulation of OPG expression and down-regulation of RANKL expression. In contrast, activation of the noncanonical pathway in osteoclast precursors enhances RANKL-induced osteoclastic differentiation. Thus, Wnt signals in osteoblasts and osteoclast precursors play important roles in osteoclastogenesis. This review summarizes the regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196156     DOI: 10.2741/3673

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  45 in total

1.  TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis.

Authors:  Karel Otero; Masahiro Shinohara; Haibo Zhao; Marina Cella; Susan Gilfillan; Angela Colucci; Roberta Faccio; F Patrick Ross; Steve L Teitelbaum; Hiroshi Takayanagi; Marco Colonna
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

2.  Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion: a novel molecular mechanism.

Authors:  Hamid Namazi
Journal:  Eur Spine J       Date:  2011-08-30       Impact factor: 3.134

3.  Hemin activation of innate cellular response blocks human immunodeficiency virus type-1-induced osteoclastogenesis.

Authors:  Kazuyo Takeda; Rewati Adhikari; Kenneth M Yamada; Subhash Dhawan
Journal:  Biochem Biophys Res Commun       Date:  2015-05-19       Impact factor: 3.575

Review 4.  Mechanisms of "kidney governing bones" theory in traditional Chinese medicine.

Authors:  Dahong Ju; Meijie Liu; Hongyan Zhao; Jun Wang
Journal:  Front Med       Date:  2014-09-09       Impact factor: 4.592

5.  hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected].

Authors:  Xi Zhao; Yonglie Chao; Pixiu Chen; Die Liu; Peng Su; Jian Sun; Xuqin Cui; Yaxiong Tang
Journal:  J Physiol Biochem       Date:  2011-11-05       Impact factor: 4.158

6.  Osteogenic differentiation of stem cells alters vitamin D receptor expression.

Authors:  Rene Olivares-Navarrete; Ken Sutha; Sharon L Hyzy; Daphne L Hutton; Zvi Schwartz; Todd McDevitt; Barbara D Boyan
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

7.  Wnt and Wnt inhibitors in bone metastasis.

Authors:  Joseph L Sottnik; Christopher L Hall; Jian Zhang; Evan T Keller
Journal:  Bonekey Rep       Date:  2012-07-04

8.  Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1.

Authors:  Min Zhu; Thomas E Van Dyke; Robert Gyurko
Journal:  FASEB J       Date:  2013-04-29       Impact factor: 5.191

9.  The central nervous system (CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures.

Authors:  Weiping Qin; Li Sun; Jay Cao; Yuanzhen Peng; Lauren Collier; Yong Wu; Graham Creasey; Jianhua Li; Yiwen Qin; Jonathan Jarvis; William A Bauman; Mone Zaidi; Christopher Cardozo
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

Review 10.  Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Authors:  J L Sottnik; E T Keller
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.